Causes of Death in Long-Term Survivors of Head and Neck Cancer

被引:149
|
作者
Baxi, Shrujal S. [1 ,2 ]
Pinheiro, Laura C. [3 ]
Patil, Sujata M. [3 ]
Pfister, David G. [1 ,2 ]
Oeffinger, Kevin C. [1 ]
Elkin, Elena B. [3 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Weill Cornell Med Coll, Dept Med, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[4] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA
基金
美国国家卫生研究院;
关键词
competing mortality; head and neck cancer; survivorship; second primary malignancy; competing risk; SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; MORTALITY; ACCURACY; DISEASE; RISK; CERTIFICATES; TRENDS; TUMORS;
D O I
10.1002/cncr.28588
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUNDSurvivors of head and neck squamous cell carcinoma (HNSCC) face excess mortality from multiple causes. METHODSWe used the population-based Surveillance, Epidemiology, and End Results (SEER) cancer registry data to evaluate the causes of death in patients with nonmetastatic HNSCC diagnosed between 1992 and 2005 who survived at least 3 years from diagnosis (long-term survivors). We used competing-risks proportional hazards regression to estimate probabilities of death from causes: HNSCC, second primary malignancy (SPM) excluding HNSCC, cardiovascular disease, and other causes. RESULTSWe identified 35,958 three-year survivors of HNSCC with a median age at diagnosis of 60 years (range=18-100 years) and a median follow-up of 7.7 years (range=3-18 years). There were 13,120 deaths during the study period. Death from any cause at 5 and 10 years was 15.4% (95% confidence interval [CI] =15.0%-15.8%) and 41.0% (95% CI=40.4%-41.6%), respectively. There were 3852 HNSCC deaths including both primary and subsequent head and neck tumors. The risk of death from HNSCC was greater in patients with nasopharynx or hypopharynx cancer and in patients with locally advanced disease. SPM was the leading cause of non-HNSCC death, and the most common sites of SPM death were lung (53%), esophagus (10%), and colorectal (5%) cancer. CONCLUSIONSMany long-term HNSCC survivors die from cancers other than HNSCC and from noncancer causes. Routine follow-up care for HNSCC survivors should expand beyond surveillance for recurrent and new head and neck cancers. Cancer 2014;120:1507-1513. (c) 2014 American Cancer Society. The cause and timing of death in a large cohort of long-term survivors of head and neck squamous cell carcinoma was evaluated. Through use of a competing risk model, varying risk of death was identified based on demographic and clinical factors including age, primary site of disease, and race.
引用
收藏
页码:1507 / 1513
页数:7
相关论文
共 50 条
  • [21] Causes of death and conditional survival estimates of long-term lung cancer survivors
    Zhang, Qun
    Dai, Yuan
    Liu, Hongda
    Sun, Wenkui
    Huang, Yuming
    Gong, Zheng
    Dai, Shanlin
    Kong, Hui
    Xie, Weiping
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] DENTAL ABNORMALITIES IN LONG-TERM SURVIVORS OF HEAD AND NECK RHABDOMYOSARCOMA
    KASTE, SC
    HOPKINS, KP
    BOWMAN, LC
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 25 (02): : 96 - 101
  • [24] Socioeconomic effects of and risk factors for disability in long-term survivors of head and neck cancer
    Vartanian, JG
    Carvalho, AL
    Toyota, J
    Kowalski, ISG
    Kowalski, LP
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2006, 132 (01) : 32 - 35
  • [25] Modeling symptom drivers of oral intake in long-term head and neck cancer survivors
    Mona Kamal
    Martha P. Barrow
    Jan S. Lewin
    Alicia Estrella
    G. Brandon Gunn
    Quiling Shi
    Theresa M. Hofstede
    David I. Rosenthal
    Clifton David Fuller
    Katherine A. Hutcheson
    [J]. Supportive Care in Cancer, 2019, 27 : 1405 - 1415
  • [26] Long-term Health-Related Quality of Life in Survivors of Head and Neck Cancer
    Funk, Gerry F.
    Karnell, Lucy Hynds
    Christensen, Alan J.
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2012, 138 (02) : 123 - 133
  • [27] Modeling symptom drivers of oral intake in long-term head and neck cancer survivors
    Kamal, Mona
    Barrow, Martha P.
    Lewin, Jan S.
    Estrella, Alicia
    Gunn, G. Brandon
    Shi, Quiling
    Hofstede, Theresa M.
    Rosenthal, David I.
    Fuller, Clifton David
    Hutcheson, Katherine A.
    [J]. SUPPORTIVE CARE IN CANCER, 2019, 27 (04) : 1405 - 1415
  • [28] The emergence of long-term survivors in recurrent and metastatic squamous cell head and neck cancer
    Castet, Florian
    Brenes, Jesus
    Taberna, Miren
    Mesia, Ricard
    [J]. CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 160 - 168
  • [29] Predicting Depression and Quality of Life among Long-term Head and Neck Cancer Survivors
    Moubayed, Sami P.
    Sampalis, John S.
    Ayad, Tareck
    Guertin, Louis
    Bissada, Eric
    Gologan, Olguta E.
    Soulieres, Denis
    Lambert, Louise
    Filion, Edith
    Nguyen-Tan, Phuc Felix
    Christopoulos, Apostolos
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 152 (01) : 91 - 97
  • [30] Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View
    Taylor, Katherine J.
    Amdal, Cecilie D.
    Bjordal, Kristin
    Astrup, Guro L.
    Herlofson, Bente B.
    Duprez, Frederic
    Gama, Ricardo R.
    Jacinto, Alexandre
    Hammerlid, Eva
    Scricciolo, Melissa
    Jansen, Femke
    Verdonck-de Leeuw, Irma M.
    Fanetti, Giuseppe
    Guntinas-Lichius, Orlando
    Inhestern, Johanna
    Dragan, Tatiana
    Fabian, Alexander
    Boehm, Andreas
    Woehner, Ulrike
    Kiyota, Naomi
    Krueger, Maximilian
    Bonomo, Pierluigi
    Pinto, Monica
    Nuyts, Sandra
    Silva, Joaquim C.
    Stromberger, Carmen
    Tramacere, Francesco
    Bushnak, Ayman
    Perotti, Pietro
    Plath, Michaela
    Paderno, Alberto
    Stempler, Noa
    Kouri, Maria
    Singer, Susanne
    [J]. HEALTHCARE, 2023, 11 (06)